Susquehanna International Group
CMND icon

Susquehanna International Group’s Clearmind Medicine CMND Stock Holding History

Susquehanna International Group’s Portfolio CMND Stock Details CMND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8
Closed -$24.9K – 12487
2025
Q3 		$24.9K Buy
+8
New +$26.1K ﹤0.01% 12016
2024
Q2 		– Sell
-7
Closed -$27.3K – 12152
2024
Q1 		$27.3K Buy
+7
New +$34.3K ﹤0.01% 11742
2023
Q4 		– Sell
-1
Closed -$7.96K – 12446
2023
Q3 		$7.96K Buy
+1
New +$36.6K ﹤0.01% 11745

Other funds holding CMND

AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Susquehanna International Group's CMND Position: Q4 2025 in Review

Susquehanna International Group sold out of Clearmind Medicine (CMND) in Q4 2025, closing a stake of 8 shares — an estimated $24.9K sold.

Susquehanna International Group first reported a position in CMND in Q3 2023 and held it in 3 quarters. The position peaked at $27.3K in Q1 2024. 1 fund tracked by Wall St. Rank holds CMND as of Q4 2025.

  • Susquehanna International Group reported no remaining Clearmind Medicine position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 8 Clearmind Medicine shares in Q4 2025, an estimated $24.9K.
  • Susquehanna International Group first reported a position in Clearmind Medicine in Q3 2023 and held it in 3 quarters.
  • Susquehanna International Group's Clearmind Medicine position peaked at $27.3K in Q1 2024.
  • 1 fund tracked by Wall St. Rank held Clearmind Medicine as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.